Just Biotherapeutics
Latest round
- Series A
Last raised
- Jul 2016
Total raised
- $29M
Investors
- 4
About Just Biotherapeutics
Just Biotherapeutics, Inc.Founded in 2014, Just Biotherapeutics, Inc. is headquartered in Seattle, US, and operates as a CDMO for biotechnology firms. The company was acquired by Evotec SE in May 2019 for USD 90 mn, marking a strategic expansion in Evotec's capabilities.Just - Evotec Biologics specializes in contract development and manufacturing organization (CDMO) services, primarily focusing on the development and cGMP manufacturing of biotherapeutics, including antibodies, next-generation biologics, and biosimilars. Their core offerings include antibody discovery, process development, and biomanufacturing, which leverage advanced continuous manufacturing technologies designed to enhance productivity and reduce costs. These services are aimed at biotechnology and pharmaceutical companies seeking efficient and reliable solutions for their therapeutic development processes. The company operates in multiple geographical markets, including North America and Europe, catering to clients from diverse sectors within the life sciences industry, including emerging biotech firms and established pharmaceutical companies that require scalable manufacturing solutions.Just - Evotec Biologics operates on a B2B transaction model, primarily engaging with clients through partnership agreements and fee-for-service contracts. The company's revenue structure is built around providing comprehensive solutions that may include co-development opportunities, integrated programs, and technology out-licensing arrangements. Clients are charged based on the services rendered, which encompass early clinical to commercial cGMP biologics manufacturing, as well as analytical and process development services. The pricing structure reflects the complexity and scale of the projects undertaken, with clients benefiting from tailored solutions that meet specific regulatory and quality standards.In the wake of the acquisition by Evotec in May 2019, Just Biotherapeutics plans to leverage its advanced continuous manufacturing technologies to design new products tailored for emerging markets. The firm aims to expand its operations in Europe and North America, targeting significant growth in these regions by 2023.
Who invested in Just Biotherapeutics
4 investors across 2 rounds
See all investors in Just Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Just Biotherapeutics
Who invested in Just Biotherapeutics?
Just Biotherapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Just Biotherapeutics raised?
Just Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Just Biotherapeutics last raise money?
Just Biotherapeutics's most recent round on record is a Series A, in Jul 2016.
What does Just Biotherapeutics do?
Just Biotherapeutics is a biotechnology company.
Where is Just Biotherapeutics headquartered?
Just Biotherapeutics is headquartered in Seattle, US.
Which VCs invest in companies like Just Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Just Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Just Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.